Stage-Specific Inhibition of MHC Class I Presentation by the Epstein-Barr Virus BNLF2a Protein during Virus Lytic Cycle

被引:77
作者
Croft, Nathan P. [1 ]
Shannon-Lowe, Claire [1 ]
Bell, Andrew I. [1 ]
Horst, Danielle [2 ]
Kremmer, Elisabeth [3 ]
Ressing, Maaike E. [2 ]
Wiertz, Emmanuel J. H. J. [4 ]
Middeldorp, Jaap M. [5 ]
Rowe, Martin [1 ]
Rickinson, Alan B. [1 ]
Hislop, Andrew D. [1 ]
机构
[1] Univ Birmingham, Sch Canc Sci, Birmingham, W Midlands, England
[2] Leiden Univ, Med Ctr, Dept Med Microbiol, Leiden, Netherlands
[3] Helmholtz Zentrum Munchen, Inst Mol Immunol, Munich, Germany
[4] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands
[5] Vrije Univ Amsterdam Med Ctr, Dept Pathol, Amsterdam, Netherlands
基金
英国医学研究理事会; 英国惠康基金;
关键词
T-CELL RESPONSE; COMPLEX CLASS-I; IMMUNE EVASION; ANTIGEN PRESENTATION; HOST SHUTOFF; CYTOMEGALOVIRUS; EXPRESSION; INFECTION; TRANSACTIVATORS; IMMUNODOMINANCE;
D O I
10.1371/journal.ppat.1000490
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The gamma-herpesvirus Epstein-Barr virus (EBV) persists for life in infected individuals despite the presence of a strong immune response. During the lytic cycle of EBV many viral proteins are expressed, potentially allowing virally infected cells to be recognized and eliminated by CD8(+) T cells. We have recently identified an immune evasion protein encoded by EBV, BNLF2a, which is expressed in early phase lytic replication and inhibits peptide-and ATP-binding functions of the transporter associated with antigen processing. Ectopic expression of BNLF2a causes decreased surface MHC class I expression and inhibits the presentation of indicator antigens to CD8(+) T cells. Here we sought to examine the influence of BNLF2a when expressed naturally during EBV lytic replication. We generated a BNLF2a-deleted recombinant EBV (Delta BNLF2a) and compared the ability of Delta BNLF2a and wild-type EBV-transformed B cell lines to be recognized by CD8(+) T cell clones specific for EBV-encoded immediate early, early and late lytic antigens. Epitopes derived from immediate early and early expressed proteins were better recognized when presented by DBNLF2a transformed cells compared to wild-type virus transformants. However, recognition of late antigens by CD8(+) T cells remained equally poor when presented by both wildtype and Delta BNLF2a cell targets. Analysis of BNLF2a and target protein expression kinetics showed that although BNLF2a is expressed during early phase replication, it is expressed at a time when there is an upregulation of immediate early proteins and initiation of early protein synthesis. Interestingly, BNLF2a protein expression was found to be lost by late lytic cycle yet Delta BNLF2a-transformed cells in late stage replication downregulated surface MHC class I to a similar extent as wild-type EBV-transformed cells. These data show that BNLF2a-mediated expression is stage-specific, affecting presentation of immediate early and early proteins, and that other evasion mechanisms operate later in the lytic cycle.
引用
收藏
页数:13
相关论文
共 42 条
  • [1] REGULATION OF HUMAN CYTOMEGALOVIRUS US3 GENE-TRANSCRIPTION BY A CIS-REPRESSIVE SEQUENCE
    BIEGALKE, BJ
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (09) : 5362 - 5367
  • [2] The Immune Evasion Paradox: Immunoevasins of Murine Cytomegalovirus Enhance Priming of CD8 T Cells by Preventing Negative Feedback Regulation-
    Boehm, Verena
    Simon, Christian O.
    Podlech, Juergen
    Seckert, Christof K.
    Gendig, Dorothea
    Deegen, Petra
    Gillert-Marien, Dorothea
    Lemmermann, Niels A. W.
    Holtappels, Rafaela
    Reddehase, Matthias J.
    [J]. JOURNAL OF VIROLOGY, 2008, 82 (23) : 11637 - 11650
  • [3] SPECIFIC CYTOTOXIC T-LYMPHOCYTES RECOGNIZE THE IMMEDIATE-EARLY TRANSACTIVATOR ZTA OF EPSTEIN-BARR-VIRUS
    BOGEDAIN, C
    WOLF, H
    MODROW, S
    STUBER, G
    JILG, W
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (08) : 4872 - 4879
  • [4] THE EPSTEIN-BARR VIRUS (EBV) EARLY PROTEIN-EB2 IS A POSTTRANSCRIPTIONAL ACTIVATOR EXPRESSED UNDER THE CONTROL OF EBV TRANSCRIPTION FACTOR-EB1 AND FACTOR-R
    BUISSON, M
    MANET, E
    TRESCOLBIEMONT, MC
    GRUFFAT, H
    DURAND, B
    SERGEANT, A
    [J]. JOURNAL OF VIROLOGY, 1989, 63 (12) : 5276 - 5284
  • [5] Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells
    Delecluse, HJ
    Hilsendegen, T
    Pich, D
    Zeidler, R
    Hammerschmidt, W
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (14) : 8245 - 8250
  • [6] The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators
    Feederle, R
    Kost, M
    Baumann, M
    Janz, A
    Drouet, E
    Hammerschmidt, W
    Delecluse, HJ
    [J]. EMBO JOURNAL, 2000, 19 (12) : 3080 - 3089
  • [7] Murine cytomegalovirus interference with antigen presentation has little effect on the size or the effector memory phenotype of the CD8 T cell response
    Gold, MC
    Munks, MW
    Wagner, M
    McMahon, CW
    Kelly, A
    Kavanagh, DG
    Slifka, MK
    Koszinowski, UH
    Raulet, DH
    Hill, AB
    [J]. JOURNAL OF IMMUNOLOGY, 2004, 172 (11) : 6944 - 6953
  • [8] MHC class I alleles and their exploration of the antigen-processing machinery
    Groothuis, TAM
    Griekspoor, AC
    Neijssen, JJ
    Herberts, CA
    Neefjes, JJ
    [J]. IMMUNOLOGICAL REVIEWS, 2005, 207 : 60 - 76
  • [9] Epitope-specific evolution of human CD8+ T cell responses from primary to persistent phases of Epstein-Barr virus infection
    Hislop, AD
    Annels, NE
    Gudgeon, NH
    Leese, AM
    Rickinson, AB
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (07) : 893 - 905
  • [10] A CD8+ T cell immune evasion protein specific to Epstein-Barr virus and its close relatives in Old World primates
    Hislop, Andrew D.
    Ressing, Maaike E.
    van Leeuwen, Daphne
    Pudney, Victoria A.
    Horst, Danielle
    Koppers-Lalic, Danijela
    Croft, Nathan P.
    Neefjes, Jacques J.
    Rickinson, Alan B.
    Wiertz, Emmanuel J. H. J.
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 204 (08) : 1863 - 1873